Conscio Group

Are you passionate about accelerating time-to-market for Biosimilars? 🤔 Join our webinar: "Expediting Biosimilar development: Streamlining the path from research to market". Join us for a webinar where industry experts will share insights on the latest trends in biosimilars incl. accelerated biosimilar approvals through Phase 3 waivers. 📢 Hear from Martin Baur (Midas Pharma), Elena Guillen Benitez, MD, PhD (Leiden University Medical Center), and Klemens Weitenthaler (Conscio Group). 🕑 Date and Time: December 12, 2:00 PM CET 🔗 Register for free and discover new perspectives: https://lnkd.in/e3aYGykK Walk away with insights that can directly benefit your projects.

👩🔬 When your laboratory is at capacity and overwhelmed with samples, quality control and research departments are struggling to maintain pace, formulation development requires focus, clinical trials are on the horizon, skilled analysts are in short supply, and effective solutions appear elusive – consider outsourcing as a strategic option to address these challenges. 🔹 Join us at the Pharma Outsourcing conference in Stockholm on December 3 to explore how Conscio Group can resolve challenges across the drug development and manufacturing spectrum. Jiri Raska, Chief Commercial Officer at Conscio Group Pharma, will discuss how our formulation, analytical, and clinical services can accelerate your drug development. 📩 Book a meeting: jiri.raska@consciogroup.com 💡Special opportunity: All non-service providers can register for free! Just leave a comment or send an email to Jiří and we will send you a VIP registration link. 🆕 Breaking into the US market? Conscio Group can seamlessly support your transition. Through our strategic partner Kiel Laboratories, Inc. in the USA, we offer an array of services directly within the US regulatory framework. Read more about this partnership and how Kiel can help bring your products to the American market: https://lnkd.in/enkKQEEx

Are you looking for state-of-the-art analytical services for small molecules, biologics and biosimilars? 🤔 Join us at the PharmaLab Congress 2024 for the latest insights in pharmaceutical analysis and to discuss your projects with us! We’ll be there from November 25–27 in Düsseldorf, Germany. ✔️ At Booth 51, you'll have the opportunity to connect with Pavel Pihera, the Head of Sales and Business Development at QUINTA-ANALYTICA, a Conscio Group company. Pavel will be available to discuss your analytical needs and how Quinta-Analytica can support your projects. 📅 Book a meeting: pavel.pihera@consciogroup.com Can’t make it to the event? Discover our range of services online: www.consciogroup.com or dive into our latest case study about Determination of total bound iron in human blood serum samples as a showcase of our capabilities: https://lnkd.in/em_i3fUX

Are you looking to maximize the full potential of your drug development journey? 🤔 Meet us at BIO Europe 2024 in Stockholm, from November 4–6! Bohdan Řanda, Business Development Manager at Quinta-Analytica, a member of Conscio Group, will be there to discuss how we can accelerate your drug development program with our comprehensive formulation, analytical, and clinical services. 🔷 Book a meeting: bohdan.randa@consciogroup.com Can’t attend? No problem! Explore our pharmaceutical capabilities at www.consciogroup.com

Farewell Milan 🔛 Welcome Frankfurt! Together with our group companies — QUINTA-ANALYTICA, Gen-Plus GmbH & Co. KG, EL Labs, LVA GmbH, Reference Analytics GmbH and our strategic partner Kiel Laboratories, Inc.— we want to thank you for being part of this incredible journey with us at CPHI 2024. 🔝 We’re already looking forward to seeing you at CPHI 2025 in Frankfurt, Germany. 🔜 Save the date, and we’ll see you soon! #CPHI2024 #CPHI2025 #PharmaceuticalIndustry #Biosimilars #PharmaPartnerships #InnovationInPharma #ConscioGroup #QuintaAnalytica #GenPlus #LVA #ELLabs #referenceanalytics

The final day of CPHI Milan is here, but we’re not done yet! As CPHI Milan 2024 nears its end, our team at booth #22G4 is still fully ready for business discussions. Whether you’re interested in our comprehensive biosimilar services or want to explore new partnership opportunities, our experts are here to assist you until the very last minute. 🔵 Don’t miss your chance to connect with Conscio Group and discover how we can accelerate your biosimilar projects with precision and innovation. 💬 Not at the event? No worries! You can still reach out to us or explore our new Biosimilars landing page: https://lnkd.in/ehdJHCKY or if you want to learn more about what we do, visit us anytime at www.consciogroup.com. #CPHI2024 #Biosimilars #PharmaPartnerships #InnovationInPharma #ConscioGroup

👋 Conscio Group is live at CPHI Milan! We’re thrilled to connect with industry leaders and innovators at CPHI 2024. At the heart of our showcase? Our cutting-edge analytical and clinical testing services designed to help you navigate regulatory pathways and bring high-quality treatments to market faster. Stop by our booth #22G4 to learn how we can support your product development journey with tailored, high-impact solutions. 💬 Can’t make it? Visit our web page to learn more: www.consciogroup.com #CPHI2024 #Biosimilars #PharmaInnovation #ClinicalTrials #ConscioGroup

🌍 CPHI Milan has just begun, and it’s time to meet us! At Conscio Group, we are proud to showcase our leading services at one of the biggest pharmaceutical events of the year—CPHI Milan 2024. Visit us at booth 22G4, where our experts are ready to discuss how we can accelerate your development projects with our comprehensive analytical testing and clinical services. 🚀 Plus, don’t miss the chance to meet our strategic partner, Kiel Laboratories, Inc. from the USA, who specializes in helping pharmaceutical companies bring new drugs to market, particularly through the 505(b)(2) process of US FDA approval. 💬 Can’t make it? Explore our new Biosimilars landing page for an overview of what we offer: https://lnkd.in/ehdJHCKY #CPHI2024 #Biosimilars #Pharmaceuticals #HealthcareInnovation #ConscioGroup

🌟 We’re heading to CPHI Milan 2024! Conscio Group is excited to be part of CPHI Milan, where the world’s pharmaceutical leaders gather to shape the future of healthcare. We’ll be showcasing our expert biosimilar services, demonstrating how we accelerate success with precision, speed, and innovation. ✔ If you're attending, be sure to visit us and discover how our tailored solutions — including analytical method development, clinical trials, bioanalytical testing, and quality control — can support your biosimilar journey. ❗ Not attending? Contact us today and speak to one of our experts about our services: https://lnkd.in/eaTEYXZA Also, check out our new landing page focused on biosimilar analysis: https://lnkd.in/ehdJHCKY #CPHI2024 #Biosimilars #PharmaInnovation #ClinicalTrials #BioanalyticalTesting #ConscioGroup

🌐 New Strategic Partnership to Accelerate Global Drug Development.   We’re excited to announce a new strategic partnership with Kiel Laboratories, Inc. This collaboration combines Conscio Group's comprehensive services in formulation development, analytical testing, and clinical trials with Kiel Laboratories' deep expertise in U.S. market dynamics and regulatory strategies, particularly in 505(b)(2) and ANDA development programs.   🔗 Read the full announcement here: https://lnkd.in/edBRBnaT   Interested to learn more? Meet both of our teams at CPHI 2024 next week at booth #22G4! #consciogroup #kiellaboratories #newpartnership #pharmaceuticalindustry #pharmadevelopment